1AD 3.85% 2.5¢ adalta limited

Ann: Positive AD-214 Phase I extension study results, page-199

  1. 3,367 Posts.
    lightbulb Created with Sketch. 353
    If its not the right deal with Pharma they may choose the funding route and go Phase II alone to extract more value. Then partner or sell at Phase III (assuming P2 was a success) It can play out multiple ways both with pros and cons. 'Anchoring bias' is interesting and explains the posts here.
    Last edited by asx11: 27/03/24
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
-0.001(3.85%)
Mkt cap ! $14.89M
Open High Low Value Volume
2.6¢ 2.6¢ 2.5¢ $8.181K 325.6K

Buyers (Bids)

No. Vol. Price($)
2 1366992 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 36539 1
View Market Depth
Last trade - 12.05pm 27/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.